Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collabor...

by Jennifer Ibrahim, Lisa H. Underhill, John S. Taylor, Jennifer Angell, M. Judith Peterschmitt
Published 2016-09-01

Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1

by M. Judith Peterschmitt, Selena Freisens, Lisa H. Underhill, Meredith C. Foster, Grace Lewis, Sebastiaan J. M. Gaemers
Published 2019-06-01